![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Founded
Address
BioRelix Inc
5 Science Park
401 Winchester Avenue
New Haven, CT 06511
United States
Phone
Website
KANDO id: 452786
Corporate information
Official name
BioRelix Inc
Registration country
Official identities
US CIK 0001373982
Company type
Advanced fight against drug resistant microbes by attacking novel targets with novel drugs.Funding rounds
N/A USD 269,000
USD 269,000 ( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Connecticut Innovations Inc (CI) | USD 269,000 (USD 269,000) Led the round. |
N/A USD 2,560,000
USD 2,560,000 ( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
OpGen Inc | Provider of Whole Genome Mapping technologies for high-precision microbial analysis markets. | ||
| Brian Dixon | Individual investor. | |||
|
New Leaf Venture Partners (NLV) | Follow-on investment. | ||
|
Novartis Venture Funds | The corporate venturing arm of Novartis. | Follow-on investment. |
Series A USD 25,750,000
USD 25,750,000 ( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
CHL Medical Partners (Ronald W Lennox) | Venture capital firm focused on early-stage healthcare sectors. | Follow-on investment. Led the round. | |
|
Aisling Capital | Initial investment. | ||
|
|
New Leaf Venture Partners (NLV) | Initial investment. | ||
|
|
Alexandria Real Estate Equities Inc | Follow-on investment. | ||
|
|
Elm Street Ventures | Follow-on investment. | ||
|
|
Novartis Venture Funds | The corporate venturing arm of Novartis. | Follow-on investment. |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
Alexandria Real Estate Equities Inc | Initial investment. | ||
|
|
CHL Medical Partners | Venture capital firm focused on early-stage healthcare sectors. | Initial investment. | |
|
|
Elm Street Ventures | Initial investment. | ||
|
|
Novartis Venture Funds | The corporate venturing arm of Novartis. | Initial investment. |
Investment activity status
Active investor